Ocrelizumab reccommended for relapsing remitting multiple sclerosis
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
List view / Grid view
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
Ocrelizumab provides a new treatment option for adults with active relapsing forms of multiple sclerosis...